VERAMARX INC.
Veramarx offers the only accurate diagnostic test for early-stage Lyme disease, which is one of the fastest growing infectious disease in the US and Western Europe. Lyme disease can only be treated effectively when diagnosed at the early stage of infection, when 75% of patients visit the doctor. Current tests are highly inaccurate, missing over 60% of the cases in the early stage. The proprietary Veramarx test is 92% sensitive at the critical early stage of Lyme disease infection, when the disease is still treatable. Veramarx also has 99% negative predictive value, to rule out Lyme disease.
VERAMARX INC.
Industry:
Clinical Trials Health Diagnostics
Founded:
2012-01-01
Address:
Dedham, Massachusetts, United States
Country:
United States
Website Url:
http://www.veramarx.com
Total Employee:
1+
Status:
Active
Total Funding:
500 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Euro Google GStatic Google Static Content Google Cloud Sectigo SSL
Similar Organizations
UE LifeSciences
UE LifeSciences is a female technology company building preventive oncology solutions for primary care and home.
Current Employees Featured
Founder
Investors List
gener8tor
gener8tor investment in Seed Round - Veramarx Inc.
SoundBoard Venture Fund
SoundBoard Venture Fund investment in Seed Round - Veramarx Inc.
Newest Events participated
Official Site Inspections
http://www.veramarx.com
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.186
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147